Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms.

PubWeight™: 3.85‹?› | Rank: Top 1%

🔗 View Article (PMID 2045903)

Published in J Neurosurg on July 01, 1991

Authors

C H Tator1, M G Fehlings

Author Affiliations

1: Division of Neurosurgery, Toronto Hospital, University of Toronto, Ontario, Canada.

Associated clinical trials:

Cerebrospinal Fluid Drainage (CSFD) in Acute Spinal Cord Injury | NCT02495545

Articles citing this

(truncated to the top 100)

Early versus delayed decompression for traumatic cervical spinal cord injury: results of the Surgical Timing in Acute Spinal Cord Injury Study (STASCIS). PLoS One (2012) 3.90

Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx (2004) 1.98

Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury. J Clin Invest (2007) 1.84

Mechanisms of chronic central neuropathic pain after spinal cord injury. Brain Res Rev (2008) 1.69

Spinal cord injury I: A synopsis of the basic science. Can Vet J (2010) 1.58

Significant correlation between cerebrospinal fluid nitric oxide concentrations and neurologic prognosis in incomplete cervical cord injury. Eur Spine J (2007) 1.51

De novo expression of Trpm4 initiates secondary hemorrhage in spinal cord injury. Nat Med (2009) 1.42

Systemic bisperoxovanadium activates Akt/mTOR, reduces autophagy, and enhances recovery following cervical spinal cord injury. PLoS One (2012) 1.30

Brief suppression of Abcc8 prevents autodestruction of spinal cord after trauma. Sci Transl Med (2010) 1.28

Pregabalin as a neuroprotector after spinal cord injury in rats. Eur Spine J (2008) 1.27

Advances in stem cell therapy for spinal cord injury. J Clin Invest (2012) 1.24

Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions. PLoS One (2012) 1.14

Thoracolumbar burst fractures without neurological deficit: the role for conservative treatment. Eur Spine J (2009) 1.14

The current state-of-the-art of spinal cord imaging: applications. Neuroimage (2013) 1.13

A prospective, multicenter, phase I matched-comparison group trial of safety, pharmacokinetics, and preliminary efficacy of riluzole in patients with traumatic spinal cord injury. J Neurotrauma (2013) 1.13

Rescuing vasculature with intravenous angiopoietin-1 and alpha v beta 3 integrin peptide is protective after spinal cord injury. Brain (2010) 1.13

Spatio-temporal progression of grey and white matter damage following contusion injury in rat spinal cord. PLoS One (2010) 1.11

Treadmill exercise reduces spinal cord injury-induced apoptosis by activating the PI3K/Akt pathway in rats. Exp Ther Med (2013) 1.07

Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings. Neurosurg Rev (2003) 1.06

Mean Arterial Blood Pressure Correlates with Neurological Recovery after Human Spinal Cord Injury: Analysis of High Frequency Physiologic Data. J Neurotrauma (2015) 1.05

Characterization of vascular disruption and blood-spinal cord barrier permeability following traumatic spinal cord injury. J Neurotrauma (2014) 1.04

Conduction failure following spinal cord injury: functional and anatomical changes from acute to chronic stages. J Neurosci (2011) 1.04

Multiple channel bridges for spinal cord injury: cellular characterization of host response. Tissue Eng Part A (2009) 1.02

Cellular treatments for spinal cord injury: the time is right for clinical trials. Neurotherapeutics (2011) 1.01

Imatinib enhances functional outcome after spinal cord injury. PLoS One (2012) 0.98

Glibenclamide for the treatment of acute CNS injury. Pharmaceuticals (Basel) (2013) 0.96

Delayed post-injury administration of riluzole is neuroprotective in a preclinical rodent model of cervical spinal cord injury. J Neurotrauma (2013) 0.96

Neuroprotective effects of perflurocarbon (oxycyte) after contusive spinal cord injury. J Neurotrauma (2013) 0.95

Topological data analysis for discovery in preclinical spinal cord injury and traumatic brain injury. Nat Commun (2015) 0.95

Emerging approaches to the surgical management of acute traumatic spinal cord injury. Neurotherapeutics (2011) 0.94

Hemodynamic parameters and timing of surgical decompression in acute cervical spinal cord injury. J Spinal Cord Med (2007) 0.94

Transplantation of Induced Pluripotent Stem Cell-Derived Neural Stem Cells Mediate Functional Recovery Following Thoracic Spinal Cord Injury Through Remyelination of Axons. Stem Cells Transl Med (2015) 0.94

Loss and spontaneous recovery of forelimb evoked potentials in both the adult rat cuneate nucleus and somatosensory cortex following contusive cervical spinal cord injury. Exp Neurol (2007) 0.93

Targeting microvasculature for neuroprotection after SCI. Neurotherapeutics (2011) 0.93

Effects of zileuton and montelukast in mouse experimental spinal cord injury. Br J Pharmacol (2007) 0.93

Evaluation of Injured Axons Using Two-Photon Excited Fluorescence Microscopy after Spinal Cord Contusion Injury in YFP-H Line Mice. Int J Mol Sci (2015) 0.92

Immunoglobulin G (IgG) attenuates neuroinflammation and improves neurobehavioral recovery after cervical spinal cord injury. J Neuroinflammation (2012) 0.92

Meta-analysis of pre-clinical studies of early decompression in acute spinal cord injury: a battle of time and pressure. PLoS One (2013) 0.92

Matrix metalloproteinase-9 deficiency leads to prolonged foreign body response in the brain associated with increased IL-1beta levels and leakage of the blood-brain barrier. Matrix Biol (2009) 0.91

Plasticity of the injured human spinal cord: insights revealed by spinal cord functional MRI. PLoS One (2012) 0.91

The role of inducible nitric oxide synthase following spinal cord injury in rat. J Korean Med Sci (2005) 0.90

In vivo longitudinal MRI and behavioral studies in experimental spinal cord injury. J Neurotrauma (2010) 0.90

Retracted Serotonin 5-HT7 receptor agonist, LP-211, exacerbates Na(+), K(+)-ATPase/Mg(2+)-ATPase imbalances in spinal cord-injured male rats. Diagn Pathol (2015) 0.90

Valproic acid protects motor neuron death by inhibiting oxidative stress and endoplasmic reticulum stress-mediated cytochrome C release after spinal cord injury. J Neurotrauma (2014) 0.90

Salmon fibrin treatment of spinal cord injury promotes functional recovery and density of serotonergic innervation. Exp Neurol (2012) 0.90

Dantrolene can reduce secondary damage after spinal cord injury. Eur Spine J (2009) 0.90

Effect of spinal cord compression on local vascular blood flow and perfusion capacity. PLoS One (2014) 0.89

Acute complications of spinal cord injuries. World J Orthop (2015) 0.89

Emerging therapies for acute traumatic spinal cord injury. CMAJ (2012) 0.88

A retinoic acid receptor beta agonist (CD2019) overcomes inhibition of axonal outgrowth via phosphoinositide 3-kinase signalling in the injured adult spinal cord. Neurobiol Dis (2009) 0.88

Critical ischemia time in a model of spinal cord section. A study performed on dogs. Eur Spine J (2006) 0.88

A mouse model of photochemically induced spinal cord injury. J Korean Neurosurg Soc (2009) 0.88

The influence of time from injury to surgery on motor recovery and length of hospital stay in acute traumatic spinal cord injury: an observational Canadian cohort study. J Neurotrauma (2014) 0.87

Genome-wide gene expression profiling of stress response in a spinal cord clip compression injury model. BMC Genomics (2013) 0.86

Diffuse axonal damage, myelin impairment, astrocytosis and inflammatory response following microinjections of NMDA into the rat striatum. Inflammation (2007) 0.86

Role of early surgical decompression of the intradural space after cervical spinal cord injury in an animal model. J Bone Joint Surg Am (2010) 0.86

1H-MRS in spinal cord injury: acute and chronic metabolite alterations in rat brain and lumbar spinal cord. Eur J Neurosci (2011) 0.86

Rationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): a randomized, double-blinded, placebo-controlled parallel multi-center trial. Spinal Cord (2015) 0.85

Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury. Eur Spine J (2004) 0.85

Acceleration of blood-brain barrier formation after transplantation of enteric glia into spinal cords of rats. Exp Brain Res (2004) 0.85

Simvastatin ameliorates cauda equina compression injury in a rat model of lumbar spinal stenosis. J Neuroimmune Pharmacol (2012) 0.85

Multishot diffusion-weighted MR imaging features in acute trauma of spinal cord. Eur Radiol (2013) 0.84

Different TLR4 expression and microglia/macrophage activation induced by hemorrhage in the rat spinal cord after compressive injury. J Neuroinflammation (2013) 0.84

Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury. CNS Neurol Disord Drug Targets (2008) 0.84

Immunoglobulin G: a potential treatment to attenuate neuroinflammation following spinal cord injury. J Clin Immunol (2010) 0.84

Sustained expression of vascular endothelial growth factor and angiopoietin-1 improves blood-spinal cord barrier integrity and functional recovery after spinal cord injury. J Neurotrauma (2010) 0.84

Differential effects of 670 and 830 nm red near infrared irradiation therapy: a comparative study of optic nerve injury, retinal degeneration, traumatic brain and spinal cord injury. PLoS One (2014) 0.84

Intravenous multipotent adult progenitor cell treatment decreases inflammation leading to functional recovery following spinal cord injury. Sci Rep (2015) 0.83

Early microvascular reactions and blood-spinal cord barrier disruption are instrumental in pathophysiology of spinal cord injury and repair: novel therapeutic strategies including nanowired drug delivery to enhance neuroprotection. J Neural Transm (Vienna) (2010) 0.83

Olprinone attenuates the acute inflammatory response and apoptosis after spinal cord trauma in mice. PLoS One (2010) 0.83

Bilateral contusion-compression model of incomplete traumatic cervical spinal cord injury. J Neurotrauma (2014) 0.82

Transplanting p75-suppressed bone marrow stromal cells promotes functional behavior in a rat model of spinal cord injury. Iran Biomed J (2013) 0.82

Human spinal cord injury causes specific increases in surface expression of β integrins on leukocytes. J Neurotrauma (2011) 0.82

Delayed administration of a bio-engineered zinc-finger VEGF-A gene therapy is neuroprotective and attenuates allodynia following traumatic spinal cord injury. PLoS One (2014) 0.82

Early Blockade of TLRs MyD88-Dependent Pathway May Reduce Secondary Spinal Cord Injury in the Rats. Evid Based Complement Alternat Med (2012) 0.82

Repetitive Treatment with Diluted Bee Venom Attenuates the Induction of Below-Level Neuropathic Pain Behaviors in a Rat Spinal Cord Injury Model. Toxins (Basel) (2015) 0.82

Treatment with green tea extract attenuates secondary inflammatory response in an experimental model of spinal cord trauma. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.82

Spinal cord injury: From inflammation to glial scar. Surg Neurol Int (2011) 0.82

Reduction in antioxidant enzyme expression and sustained inflammation enhance tissue damage in the subacute phase of spinal cord contusive injury. J Biomed Sci (2011) 0.82

Mechanical and cellular processes driving cervical myelopathy. World J Orthop (2016) 0.81

Effects of methylprednisolone and ganglioside GM-1 on a spinal lesion: a functional analysis. Clinics (Sao Paulo) (2008) 0.81

Transplantation of mononuclear cells from human umbilical cord blood promotes functional recovery after traumatic spinal cord injury in Wistar rats. Braz J Med Biol Res (2011) 0.81

"Low-intensity laser therapy effect on the recovery of traumatic spinal cord injury". Lasers Med Sci (2014) 0.80

Bcl-2 in suppressing neuronal apoptosis after spinal cord injury. World J Emerg Med (2011) 0.80

Magnesium sulfate treatment in experimental spinal cord injury: emphasis on vascular changes and early clinical results. Neurosurg Rev (2003) 0.80

Does dexmedetomidine reduce secondary damage after spinal cord injury? An experimental study. Eur Spine J (2009) 0.80

Very high resolution ultrasound imaging for real-time quantitative visualization of vascular disruption after spinal cord injury. J Neurotrauma (2014) 0.80

The potential role of heat shock proteins in acute spinal cord injury. Eur Spine J (2014) 0.80

The antioxidant effect of beta-Glucan on oxidative stress status in experimental spinal cord injury in rats. Neurosurg Rev (2005) 0.80

Effects of methylprednisolone on the neural conduction of the motor evoked potentials in spinal cord injured rats. J Korean Med Sci (2005) 0.80

Prehospital use of cervical collars in trauma patients: a critical review. J Neurotrauma (2013) 0.80

Segmentation of the human spinal cord. MAGMA (2016) 0.80

Neurologic Intensive Care Unit Catastrophes: Airway, Breathing, and Circulation. Curr Treat Options Neurol (2000) 0.79

Panax ginseng Improves Functional Recovery after Contusive Spinal Cord Injury by Regulating the Inflammatory Response in Rats: An In Vivo Study. Evid Based Complement Alternat Med (2015) 0.79

Hypothermia protects human neurons. Int J Stroke (2014) 0.79

Molecular imaging in stem cell therapy for spinal cord injury. Biomed Res Int (2014) 0.79

Recent advances in the pharmacologic treatment of spinal cord injury. Metab Brain Dis (2014) 0.79

Current and future medical therapeutic strategies for the functional repair of spinal cord injury. World J Orthop (2015) 0.79

Cervical spine alignment during on-field management of potential catastrophic spine injuries. Sports Health (2009) 0.79

Value of diffusion-weighted MR imaging in acute cervical cord injury as a predictor of outcome. Neuroradiology (2006) 0.79

Articles by these authors

Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine (Phila Pa 1976) (2001) 4.09

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord (2006) 3.55

Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures. Spinal Cord (2006) 2.28

Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. J Neurosurg (1998) 1.58

Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience (2001) 1.55

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethics. Spinal Cord (2006) 1.51

A systematic review of the evidence supporting a role for vasopressor support in acute SCI. Spinal Cord (2009) 1.50

Occipital condyle fractures. Neurosurgery (1997) 1.47

C1-C2 posterior cervical fusion: long-term evaluation of results and efficacy. Neurosurgery (1995) 1.42

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design. Spinal Cord (2006) 1.39

Changes in axonal physiology and morphology after chronic compressive injury of the rat thoracic spinal cord. Neuroscience (2001) 1.37

Multilevel anterior cervical corpectomy and fibular allograft fusion for cervical myelopathy. J Neurosurg (1997) 1.34

Role of NMDA and non-NMDA ionotropic glutamate receptors in traumatic spinal cord axonal injury. J Neurosci (1997) 1.33

Autonomic dysreflexia and primary afferent sprouting after clip-compression injury of the rat spinal cord. J Neurotrauma (2001) 1.29

Mechanisms of secondary injury to spinal cord axons in vitro: role of Na+, Na(+)-K(+)-ATPase, the Na(+)-H+ exchanger, and the Na(+)-Ca2+ exchanger. J Neurosci (1996) 1.24

Evaluation of the neuroprotective effects of sodium channel blockers after spinal cord injury: improved behavioral and neuroanatomical recovery with riluzole. J Neurosurg (2001) 1.23

Mechanisms of axonal dysfunction after spinal cord injury: with an emphasis on the role of voltage-gated potassium channels. Brain Res Brain Res Rev (2001) 1.23

Pyogenic spondylodiscitis: an overview. J Infect Public Health (2010) 1.22

The Rick Hansen Spinal Cord Injury Registry (RHSCIR): a national patient-registry. Spinal Cord (2011) 1.19

Predictors of hospital mortality and mechanical ventilation in patients with cervical spinal cord injury. Can J Anaesth (1998) 1.15

The current state-of-the-art of spinal cord imaging: applications. Neuroimage (2013) 1.13

Somatosensory cortical atrophy after spinal cord injury: a voxel-based morphometry study. Neurology (2006) 1.12

The current state-of-the-art of spinal cord imaging: methods. Neuroimage (2013) 1.12

Pretreatment with calpain inhibitor CEP-4143 inhibits calpain I activation and cytoskeletal degradation, improves neurological function, and enhances axonal survival after traumatic spinal cord injury. J Neurochem (2000) 1.09

Surgical treatment for acute spinal cord injury study pilot study #2: evaluation of protocol for decompressive surgery within 8 hours of injury. Neurosurg Focus (1999) 1.05

Current use and timing of spinal surgery for management of acute spinal surgery for management of acute spinal cord injury in North America: results of a retrospective multicenter study. J Neurosurg (1999) 1.05

Early versus late surgery for traumatic spinal cord injury: the results of a prospective Canadian cohort study. Spinal Cord (2012) 1.02

Abnormal axonal physiology is associated with altered expression and distribution of Kv1.1 and Kv1.2 K+ channels after chronic spinal cord injury. Eur J Neurosci (2000) 1.00

Adaptation in the motor cortex following cervical spinal cord injury. Neurology (2002) 0.99

Attenuation of the electrophysiological function of the corpus callosum after fluid percussion injury in the rat. J Neurotrauma (2002) 0.98

Importance of access to research information among individuals with spinal cord injury: results of an evidenced-based questionnaire. Spinal Cord (2002) 0.97

Increased calpain I-mediated proteolysis, and preferential loss of dephosphorylated NF200, following traumatic spinal cord injury. Neuroscience (1999) 0.97

Review of experimental spinal cord injury with emphasis on the local and systemic circulatory effects. Neurochirurgie (1991) 0.96

FAS deficiency reduces apoptosis, spares axons and improves function after spinal cord injury. Exp Neurol (2005) 0.96

Motor evoked potentials recorded from normal and spinal cord-injured rats. Neurosurgery (1987) 0.95

Editorial: recommendations regarding the use of methylprednisolone in acute spinal cord injury: making sense out of the controversy. Spine (Phila Pa 1976) (2001) 0.94

Review of clinical trials of neuroprotection in acute spinal cord injury. Neurosurg Focus (1999) 0.94

Role of C-afferent fibres in the mechanism of action of sacral nerve root neuromodulation in chronic spinal cord injury. BJU Int (2000) 0.94

Role of L- and N-type calcium channels in the pathophysiology of traumatic spinal cord white matter injury. Neuroscience (2000) 0.93

Relationship between severity of spinal cord injury and abnormalities in neurogenic cardiovascular control in conscious rats. J Neurotrauma (1998) 0.92

Dynamic role of kallikrein 6 in traumatic spinal cord injury. Eur J Neurosci (2006) 0.92

Optimal treatment for severe neurogenic bowel dysfunction after chronic spinal cord injury: a decision analysis. Br J Surg (2007) 0.90

Changes in glial cell white matter AMPA receptor expression after spinal cord injury and relationship to apoptotic cell death. Exp Neurol (2003) 0.88

Summary statement: the use of methylprednisolone in acute spinal cord injury. Spine (Phila Pa 1976) (2001) 0.87

Myxopapillary ependymoma: correlation of clinical and imaging features with surgical resectability in a series with long-term follow-up. Spinal Cord (2011) 0.87

Role of group I metabotropic glutamate receptors in traumatic spinal cord white matter injury. J Neurotrauma (1998) 0.87

The p75 neurotrophin receptor is essential for neuronal cell survival and improvement of functional recovery after spinal cord injury. Neuroscience (2007) 0.87

The optimal radiologic method for assessing spinal canal compromise and cord compression in patients with cervical spinal cord injury. Part I: An evidence-based analysis of the published literature. Spine (Phila Pa 1976) (1999) 0.86

Serial recording of somatosensory and myoelectric motor evoked potentials: role in assessing functional recovery after graded spinal cord injury in the rat. J Neurotrauma (1997) 0.86

International spinal cord injury spinal column injury basic data set. Spinal Cord (2012) 0.85

Advanced MR imaging techniques and characterization of residual anatomy. Clin Neurol Neurosurg (2012) 0.85

Neural stem cells in regenerative medicine: bridging the gap. Panminerva Med (2010) 0.82

Diagnostic criteria of traumatic central cord syndrome. Part 2: a questionnaire survey among spine specialists. Spinal Cord (2010) 0.82

Intradural metastasis mimicking nerve sheath tumor. Spine (Phila Pa 1976) (1995) 0.82

The immunological response to spinal cord injury: helpful or harmful? Exp Neurol (2013) 0.81

Comparisons of the clinical and radiological features and surgical management of posterior fossa meningiomas and acoustic neuromas. Can J Neurol Sci (1990) 0.81

Assessment of spinal cord injury by counting corticospinal and rubrospinal neurons. Brain Res (1987) 0.79

Attitudes towards the older patients with spinal cord injury among registered nurses: a cross-sectional observational study. Spinal Cord (2009) 0.78

C1-C2 transarticular screw fixation for treatment of C1-C2 instability. J Clin Neurosci (1996) 0.78

Effect of graded spinal cord compression on cardiovascular neurons in the rostro-ventro-lateral medulla. Neuroscience (1999) 0.78

Autonomic dysreflexia after spinal cord transection or compression in 129Sv, C57BL, and Wallerian degeneration slow mutant mice. Exp Neurol (2003) 0.78

Deep cerebral venous system thrombosis: case report. Neurosurgery (1993) 0.77

Use of sensory-evoked potentials recorded from the human occiput for intraoperative physiologic monitoring of the spinal cord. Spine (Phila Pa 1976) (1995) 0.76

Management of anticoagulation following central nervous system hemorrhage in patients with high thromboembolic risk. J Thromb Haemost (2010) 0.76

The effect of the sodium channel blocker QX-314 on recovery after acute spinal cord injury. J Neurotrauma (1997) 0.76

Microdiskectomy for lumbar disk herniation: a review of 100 cases. Orthopedics (1995) 0.76

Summary statement: repair of the injured spinal cord. Spine (Phila Pa 1976) (2001) 0.75

Summary statement: the Sygen(GM-1 ganglioside) clinical trial in acute spinal cord injury. Spine (Phila Pa 1976) (2001) 0.75

Management strategies to optimize clinical outcomes after acute traumatic spinal cord injury: integration of medical and surgical approaches. J Neurosurg Sci (2012) 0.75

Current status and future prospects for the neurosurgical management of acute spinal cord injuries. Paraplegia (1987) 0.75

Assessment of a new ultrafiltration blood processing system. Can J Anaesth (1997) 0.75

Evoked potentials from direct cerebellar stimulation for monitoring of the rodent spinal cord. J Neurosurg (1992) 0.75

Blood alcohol concentration as a determinant of outcomes after traumatic spinal cord injury. Eur J Neurol (2013) 0.75

Lhermitte-Duclos disease mimicking adult-onset aqueductal stenosis. Case report. J Neurosurg (1994) 0.75

Origin of motor evoked potentials in the rat. Neurosurgery (1989) 0.75

Recording technically satisfactory somatosensory evoked potentials during spinal cord operation. Neurosurgery (1987) 0.75

A novel sensory evoked potential for selective monitoring of the ventral spinal cord: from bench to bedside. Electroencephalogr Clin Neurophysiol Suppl (1996) 0.75